Michelle M. Mezei - Publications

A Network Meta-Analysis of Hereditary Transthyretin Amyloidosis With Polyneuropathy Supports a Class Effect, Not a Ranking of Individual Drugs.

Journal: European journal of neurology

Published: July 03, 2026

Long-term efficacy and safety of vutrisiran in hereditary transthyretin amyloidosis with polyneuropathy: final analysis of the HELIOS-A randomized treatment extension.

Journal: Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis

Published: June 15, 2026

Myasthenia Gravis and Thymectomy at a Tertiary-Care Surgical Centre: A 20-Year Retrospective Review.

Journal: Current oncology (Toronto, Ont.)

Published: September 15, 2025

Diagnosis and Management of Mixed Phenotype Hereditary Transthyretin Amyloidosis: A Case-Based, Canadian Perspective.

Journal: CJC open

Published: November 25, 2024

Loss-of-function mitochondrial DNA polymerase gamma variants cause vascular smooth muscle cells to secrete a diffusible mitogenic factor.

Journal: Frontiers in physiology

Published: August 29, 2024

2023 Canadian Surgery Forum: Sept. 20-23, 2023.

Journal: Canadian journal of surgery. Journal canadien de chirurgie

Published: January 04, 2024

Macrocytosis in Mitochondrial DNA Deletion Syndromes.

Journal: Acta haematologica

Published: November 23, 2022

Ketogenic diet for mitochondrial disease: potential role in treating the Multiple Symmetric Lipomatosis phenotype associated with the common MT-TK genetic mutation.

Journal: Orphanet journal of rare diseases

Published: September 14, 2021

Canadian Guidelines for Hereditary Transthyretin Amyloidosis Polyneuropathy Management.

Journal: The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques

Published: February 25, 2021

Response from Authors to the Letter to the Editor.

Journal: The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques

Published: October 15, 2020

Epidemiological evidence for a hereditary contribution to myasthenia gravis: a retrospective cohort study of patients from North America.

Journal: BMJ open

Published: September 19, 2020

The Canadian Neuromuscular Disease Registry 2010-2019: A Decade of Facilitating Clinical Research Througha Nationwide, Pan-NeuromuscularDisease Registry.

Journal: Journal of neuromuscular diseases

Published: September 14, 2020